[Drug therapy of congestive heart failure].
Sasayama
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004070:Digitalis; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011719:Pyrazines; D011804:Quinolines / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D004232:Diuretics; D010726:Phosphodiesterase Inhibitors; D011719:Pyrazines; D011804:Quinolines; D014665:Vasodilator Agents; C041667:vesnarinone